Evaluation of antiatherogenic properties of ezetimibe using 3H-labeled low-density-lipoprotein cholesterol and 99mTc-cAbVCAM1-5 sPECT in ApoE2/2 mice fed the paigen diet

MLA

Dumas, Laurent S., et al. Evaluation of Antiatherogenic Properties of Ezetimibe Using 3H-Labeled Low-Density-Lipoprotein Cholesterol and 99mTc-CAbVCAM1-5 SPECT in ApoE2/2 Mice Fed the Paigen Diet. July 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3848..0410987423f94bee7b7aaa5e1f41f46c&authtype=sso&custid=ns315887.

APA

Dumas, L. S., Briand, F., Clerc, R., Brousseau, E., Montemagno, C., Ahmadi, M., Bacot, S., Soubies, A., Perret, P., Riou, L. M., Devoogdt, N., Lahoutte, T., Baronne-Rochette, G., Fagret, D., Ghezzi, C., Sulpice, T., & Broisat, A. (2017). Evaluation of antiatherogenic properties of ezetimibe using 3H-labeled low-density-lipoprotein cholesterol and 99mTc-cAbVCAM1-5 sPECT in ApoE2/2 mice fed the paigen diet.

Chicago

Dumas, Laurent S, François Briand, Romain Clerc, Emmanuel Brousseau, Christopher Montemagno, Mitra Ahmadi, Sandrine Bacot, et al. 2017. “Evaluation of Antiatherogenic Properties of Ezetimibe Using 3H-Labeled Low-Density-Lipoprotein Cholesterol and 99mTc-CAbVCAM1-5 SPECT in ApoE2/2 Mice Fed the Paigen Diet,” July. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3848..0410987423f94bee7b7aaa5e1f41f46c&authtype=sso&custid=ns315887.